vimarsana.com
Home
Live Updates
GlycoMimetics, Inc. (NASDAQ:GLYC) Q2 2023 Earnings Call Transcript : comparemela.com
GlycoMimetics, Inc. (NASDAQ:GLYC) Q2 2023 Earnings Call Transcript
Operator: Good morning, and thank you for joining the GlycoMimetics, Q2 2023 Earnings Call. At this time all participants are in listen-only mode.
Related Keywords
Boston ,
Massachusetts ,
United States ,
Dana Farber Cancer Institute ,
Brian Hahn ,
Christian Dinneen ,
Harout Semerjian ,
John Moran ,
John Horan ,
Glycomimetics Inc ,
Nasdaq ,
Data Monitoring Committee ,
Company Counsel At Glycomimetics ,
National Cancer Institute ,
Call Transcript August ,
Christian Dinneen Long ,
Company Counsel ,
Chief Executive Officer Brian Hahn ,
Chief Financial Officer ,
Edwin Rock ,
Chief Medical ,
Chief Medical Officer ,
Boston Children ,
Dana Farber Cancer ,
Vaso Occlusive Crisis ,
Boris Peaker ,
Boris Your ,
Roger Song ,
Healthcare Conference ,
comparemela.com © 2020. All Rights Reserved.